Document ID: chunk:federal_register_of_legislation:C2022C00026:clause:1_17
Version: federal_register_of_legislation:C2022C00026
Segment Type: clause
Provision Reference: sch 1 cl 17
Character Range: 13486–14961

17  Subsection 99ACC(6)
Repeal the subsection, substitute:

Subject to statutory price reduction etc.
 (6) The following provisions have effect:
 (a) a listed component drug contained in a drug in a combination item becomes subject to statutory price reduction if section 99ACB or 99ADH, or subsection 99ACF(1), (2), (2AB) or (2AC) because of section 99ACH, has applied to a listed brand of a pharmaceutical item that:
 (i) has the listed component drug; and
 (ii) has the same manner of administration as the combination item;
 (b) whichever provision mentioned in paragraph (a) applied, that provision applies to the listed component drug contained in the drug in the combination item in the same way as that provision applies to the listed brand of the pharmaceutical item that:
 (i) has the listed component drug; and
 (ii) has the same manner of administration as the combination item;
 (c) a listed component drug contained in a drug in a combination item becomes subject to statutory price reduction if subsection 99ACF(1) or (2) because of item 2, 3, 4, 5 or 6 in the table in section 99ACF has applied to a listed brand of a pharmaceutical item that has the listed component drug;
 (d) whichever provision mentioned in paragraph (c) applied, that provision applies to the listed component drug contained in the drug in the combination item in the same way as that provision applies to the listed brand of the pharmaceutical item that has the listed component drug.